Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study
Shukui Qin(Nanjing University of Chinese Medicine), Stephen L. Chan(Chinese University of Hong Kong), Shanzhi Gu(Hunan Cancer Hospital), Yuxian Bai(Harbin Medical University), Zhenggang Ren(Fudan University), Xiaoyan Lin(Fujian Medical University), Zhendong Chen(Anhui Medical University), Weidong Jia(Anhui Provincial Hospital), Yongdong Jin(University of Electronic Science and Technology of China), Yabing Guo(Nanfang Hospital), Xiaohua Hu(Guangxi Medical University), Zhiqiang Meng(Fudan University Shanghai Cancer Center), Jun Liang(Peking University), Ying Cheng(Jilin Province Tumor Hospital), Jianping Xiong(Nanchang University), Hong Ren(Dalian Medical University), Fang Yang(The Sixth People's Hospital of Shenyang), Wei Li(Jilin University), Yajin Chen(Sun Yat-sen University), Yong Zeng(Sichuan University), А. В. Султанбаев(Republican Oncological Clinical Dispensary), Monika Pazgan−Simon(Wroclaw Medical University), Margaryta Pisetska, Davide Melisi(University of Verona), Dmitriy Ponomarenko(State Healthcare Institution "Regional Clinical Oncological Dispensary"), Yurii Osypchuk, Ivan Sinielnikov(Linkou Chang Gung Memorial Hospital), Tsai‐Sheng Yang(Linkou Chang Gung Memorial Hospital), Liang Xiao(Jiangsu Hengrui Medicine (China)), Chunxia Chen(Jiangsu Hengrui Medicine (China)), Linna Wang(National Taiwan University Hospital), Ann-Lii Cheng(The University of Texas MD Anderson Cancer Center), Ahmed O. Kaseb(The University of Texas MD Anderson Cancer Center), Arndt Vogel(Nanjing University of Chinese Medicine), Shukui Qin(Nanjing University of Chinese Medicine), Stephen L Chan(Chinese University of Hong Kong), Ann-Lii Cheng(The University of Texas MD Anderson Cancer Center), Ahmed O. Kaseb(The University of Texas MD Anderson Cancer Center), Arndt Vogel(Medizinische Hochschule Hannover), Shanzhi Gu(Harbin Medical University), Yuxian Bai(Harbin Medical University), Zhenggang Ren(Fujian Medical University), Xiaoyan Lin(Fujian Medical University), Zhendong Chen(Anhui Medical University), Weidong Jia(University of Electronic Science and Technology of China), Yongdong Jin(University of Electronic Science and Technology of China), Yabing Guo(Guangxi Medical University), Xiaohua Hu(Guangxi Medical University), Zhiqiang Meng(Peking University), Jun Liang(Peking University), Ying Cheng(Nanchang University), Jianping Xiong(Nanchang University), Hong Ren(Dalian Medical University), Fang Yang(Jilin University), Wei Li(Sun Yat-sen University), Yajin Chen(Sun Yat-sen University), Yong Zeng(Sichuan University), А. В. Султанбаев(Wroclaw Medical University), Monika Pazgan−Simon(Wroclaw Medical University), Margaryta Pisetska(University of Verona), Davide Melisi(Azienda Ospedaliera Universitaria Integrata Verona), Dmitriy Ponomarenko(State Healthcare Institution "Regional Clinical Oncological Dispensary"), Yurii Osypchuk, Ivan Sinielnikov(Linkou Chang Gung Memorial Hospital), Tsai‐Sheng Yang(Linkou Chang Gung Memorial Hospital), Liang Xiao(Jiangsu Hengrui Medicine (China)), Chunxia Chen(Jiangsu Hengrui Medicine (China)), Linna Wang(Jiangsu Hengrui Medicine (China)), Mingxiang Zhang(National Taiwan University Hospital), Li Xu, Xianglin Yuan(University of Verona), Da Li(Jilin Province Tumor Hospital), Jierer Ying, Jingdong Zhang, Tao Zhang(Nanfang Hospital), Kangsheng Gu(National Taiwan University Hospital), Yifu He(Nanchang University), Ping Hao(University of Verona), Da Jiang(Nanjing University of Chinese Medicine), Shu Zhang, Baocai Xing, Baihong Zhang(Jiangsu Hengrui Medicine (China)), Dong Wang, Xiaofeng Zhai(Jiangsu Hengrui Medicine (China)), Houjie Liang, Bożena Cybulska-Stopa, Mikhail Dvorkin, Daniil Stroyakovskiy, M. Nechaeva, Chia‐Jui Yen(Republican Oncological Clinical Dispensary), Wei‐Wen Su(National Taiwan University Hospital), Yen‐Hao Chen(Sun Yat-sen University), Igor Bondarenko(Linkou Chang Gung Memorial Hospital), Lin Yang(The Sixth People's Hospital of Shenyang), Weijia Fang, Carlos Gómez-Martín, Min‐Hee Ryu, Hansang Kim, Jeehyun Kim, Oleg Zarubenkov, Р. В. Орлова, Elena Poddubskaya, Natalia Fadeeva, Yulia Makarova, Yee Chao, Chao‐Hung Hung, Maryna Neffa, О. І. Vynnychenko, Adam M. Burgoyne, Chunyi Hao, Raphael Mohr, Roberto Diaz-Beveridge, Jaime Feliú-Batlle, Antonio Cubillo-Gracian, Ann‐Shing Lee, Bruno Daniele, Lorenzo Antonuzzo, Angelo Sangiovanni, Antonio Gasbarrini, Mario Scartozzi, Mi Sun Ahn(Guangxi Medical University), Sung‐Yong Oh, С. В. Орлов, Hakan Harputluoğlu, Berna Öksüzoğlu, Chiun Hsu, Kun‐Ming Rau, Oleksandr Krechkovskyi, Vladimir Yareshko(Nanchang University), Henry Xiong, Fa-Chyi Lee, Yixing Jiang, Afshin Eli Gabayan, Mary K. Crow, Christophe Van Steenkiste, Gontran Verset
Cited by 654
Abstract
Related Papers
Sorafenib in Advanced Hepatocellular Carcinoma
Josep M. Llovet, Sergio Ricci, Vincenzo Mazzaferro et al.|New England Journal of Medicine|2008|12.9k